Lombard Odier Asset Management (Switzerland)’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-146,844
Closed -$2.07M 361
2021
Q4
$2.07M Buy
146,844
+1,174
+0.8% +$17.3K 0.13% 98
2021
Q3
$2.55M Buy
+145,670
New +$2.56M 0.16% 95

Other funds holding SOPH

Lombard Odier Asset Management (Switzerland)'s SOPH Position: Q1 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of SOPHiA GENETICS (SOPH) in Q1 2022, closing a stake of 146,844 shares — an estimated $2.07M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in SOPH in Q3 2021 and held it in 2 quarters. The position peaked at $2.55M in Q3 2021. 29 funds tracked by Wall St. Rank hold SOPH as of Q1 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining SOPHiA GENETICS position as of Q1 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 146,844 SOPHiA GENETICS shares in Q1 2022, an estimated $2.07M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 2 quarters.
  • Lombard Odier Asset Management (Switzerland)'s SOPHiA GENETICS position peaked at $2.55M in Q3 2021.
  • 29 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.